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Edited by Sandro SonninoAbstract Ceramide kinase (CERK) converts ceramide (Cer) to
ceramide-1-phosphate (C1P), a newly recognized bioactive
molecule capable of regulating diverse cellular functions. The
N-terminus of the CERK protein encompasses a sequence motif
known as a pleckstrin homology (PH) domain. However, little is
known regarding the functional roles of this domain in CERK. In
this study, we have demonstrated that the PH domain of CERK
is essential for its enzyme activity. Using site-directed mutagen-
esis, we have further determined that Leu10 in the PH domain
has an important role in CERK activity. Replacing this residue
with a neutral alanine or isoleucine, caused a dramatic decrease
in CERK activity to 1% and 29%, respectively, compared to
CERK, but had no eﬀect on substrate aﬃnity. The study
presented here suggests that the PH domain of CERK is not only
indispensable for its activity but also act as a regulator of CERK
activity.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Sphingolipids are now recognized as bioactive molecules
that regulate a number of signaling pathways involved in
controlling cell development, diﬀerentiation, activation and
proliferation [1–3]. One sphingolipid metabolite recently pro-
posed to be a signaling lipid [4], ceramide 1-phosphate
(C1P), is generated from ceramide (Cer) by the action of cera-
mide kinase (CERK). In fact, signaling roles have been exam-
ined for both C1P and CERK by several groups, including
ours. C1P has been reported to have mitogenic eﬀects [5] and
to mediate arachidonic acid release in response to interleu-
kin-1b and a calcium ionophore [7]. Additionally, C1P was
shown to induce the translocation of cytosolic phospholipase
A2a (cPLA2a) to the Golgi apparatus and to directly interact
with cPLA2a in vitro [8]. CERK was found to be involved inAbbreviations: Cer, ceramide; Sph, sphingosine; CERK, ceramide
kinase; SPHK, sphingosine kinase; C1P, ceramide 1-phosphate; S1P,
sphingosine 1-phosphate; PH, pleckstrin homology; DGK, diacylglyc-
erol kinase; PIP, phosphatidylinositol phosphate
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and in liposome fusion [6]. More recently, we reported that
CERK is a mediator of calcium-dependent degranulation in
mast cells [9].
CERK was originally cloned by its sequence homology to
sphingosine kinase (SPHK). SPHKs and CERK have highly
conserved C1–C5 domains [10,11], which are thought to be
involved in the maintenance of protein structure and in the
activity of the kinase. However, Asp177 in the C4 domain of
mouse SPHK1a, which we recently found to be important
for sphingosine (Sph) recognition [12], is highly conserved only
in the SPHKs. On the other hand, CERK possesses as an
N-terminal extension a PH domain (residues 8–126), which is
conserved only in CERK and not found in the SPHKs [11].
Additionally, CERK can be myristoylated on its N-terminal
glycine residue, a structural modiﬁcation known to target
proteins within membranes [11,13].
The PH domain was originally identiﬁed in pleckstrin and
has subsequently been found in more than 100 proteins with
diverse cellular functions. This domain has been the focus of
extensive structural and functional studies [14,15], yet little is
known regarding its eﬀects in CERK functions.
In the study presented here, we investigated the functional
role of the PH domain in the enzyme activity of CERK, and
found that this domain is in fact required for the kinase activ-
ity. We further determined that the Leu10 residue in the
domain is essential in this activity.2. Materials and methods
2.1. Cell culture and transfection
Human embryonic kidney cells (HEK293; ATCC CRL-1573) were
maintained on collagen-coated dishes in Dulbeccos modiﬁed Eagles
medium (Sigma) containing 10% FBS, 100 U/ml penicillin and
100 ng/ml streptomycin, at 37 C in an atmosphere containing 5%
CO2. Cells were transiently transfected with plasmids using the
LipofectAMINE plus reagent, according to the instructions from the
manufacturer (Invitrogen). Cells were lysed in buﬀer containing
10 mM HEPES, 2 mM EGTA, 1 mM dithiothreitol, 40 mM KCl,
and Completee protease inhibitor (Roche Diagnostics). Protein
concentrations of all cell lysates were determined with a BCA Protein
Assay Reagent Kit (Pierce Biotechnology).
2.2. Truncated and site-directed mutagenesis of CERK
N-terminally FLAG-tagged and untagged constructs of wild-type
CERK were generated in a pcDNA3-FLAG and pcDNA3 (Invitrogen)
vectors, respectively, as described previously [9]. The CERK truncated
mutants DN7-CERK, DN12-CERK, DN76-CERK, DPH-CERK and
PH-CERKwere generated by PCR from a murine CERK cDNA clone.ation of European Biochemical Societies.
4384 T.-J. Kim et al. / FEBS Letters 579 (2005) 4383–4388The primers used were as follows; for DN7-CERK (corresponding to
amino acids 8–531): 5 0-CGGGATCCATGGAGCCGCTGCACTC-
CG-3 0 (forward) and 5 0-GGAATTCTTATACTCTTCCTCGATTC-
CC-3 0 (reverse); for DN12-CERK (corresponding to amino acids
13–531): 5 0-CGGGATCCATGGTGCTGTGGGTGAAACGGCG-3 0
(forward) and 5 0-GGAATTCTTATACTCTTCCTCGATTCCC-3 0
(reverse); for DN76-CERK (corresponding to amino acids 77–531):
5 0-CGGGATCCATGGAAAATCCGTTCGCA-3 0 (forward) and
50-GGAATTCTTATACTCTTCCTCGATTCCC-30 (reverse); for DPH-
CERK (corresponding to amino acids 127–531): 5 0-CGGGATCCAT-
GACTTCAAGACCGAAGCACT-3 0 (forward) and 5 0-GGAATTCT-
TATACTCTTCCTCGATTCCC-3 0 (reverse); and for PH-CERK
(corresponding to amino acids 1–126): 5 0-CGGGATCCATGGGGG-
CAATGGGGGCG-3 0 (forward) and 5 0-GGAATTCTCACAGGCT-
CTCCAGCAGCCC-3 0 (reverse). For subsequent subcloning into
expression vectors, primers were designed so that the resulting CERK
cDNA fragments contained a 5 0 – BamHI restriction site and a 3 0 – stop
codon followed by a 3 0 – EcoRI site. The resulting truncated CERK
fragments were fused in frame (BamHI/EcoRI site) with a pcDNA3
vector.
From 8 to 12 amino acid residues in the PH domain of CERK were
substituted with a neutral amino acid (alanine or isoleucine) by design-
ing complementary primers. Gly2, Glu8, Pro9, Leu10, and Ser12 were
replaced by Ala or Ile using a QuikChange site-directed mutagenesis
kit (Stratagene), as described previously [16]. The mutation primers
were as follows; for Gly2 to Ala (G2A): 5 0-CTCGGATCCATGGC-
GGCAATGGGCGGCG-30 (forward) and 5 0-CGCCGCCCCCATT-
GCCGCCATGGATCCGAG-3 0 (reverse); for Glu8 to Ala (E8A):
5 0-CAATGGGGGCGGCGGCGCCGCTGCAC-30 (forward) and
5 0-GTGCAGCGGCGCCGCCCCCATTG-3 0 (reverse); for Pro9 to
Ala (P9A): 5 0-GCGGCGGAGGCGCTGCACTCCGTGCTG-3 0
(forward) and 5 0-CAGCACGGAGTGCAGCGCCTCCGCCGC-30
(reverse); for Leu10 to Ala (L10A): 5 0-GCGGCGGAGCCGGCG-
CACTCCGTGCTG-3 0 (forward) and 5 0-CAGCACGGAGTGCGC-
CGGCTCCGCCGC-3 0 (reverse); for Ser12 to Ala (S12A): 5 0-GAG-
CCGCTGCACGCCGTGCTGTGGGTG-3 0 (forward) and 5 0-CAC-
CCACAGCACGGCGTGCAGCGGCTC-30 (reverse); and for Leu10
to Ile (L10I): 5 0-GCGGCGGAGCCGATCCACTCCGTGCTG-30
(forward) and 5 0-CAGCACGGAGTGGATCGGCTCCGCCGC-3 0
(reverse). The identity of each insert was conﬁrmed by dideoxynucleo-
tide sequencing.
2.3. Western blot analysis
SDS–PAGE was performed on cell lysates using 10% acrylamide
gels according to the method of Laemmli [22]. Proteins were trans-
ferred to PVDF membranes (Millipore Corp.) and the membranes
were blocked overnight at 4 C in Tris-buﬀered saline with 0.1% Tween
20 (TBS/T), containing 5% skimmed milk powder. This was followed
by incubation with a 1:1000 dilution of the monoclonal anti-FLAG
antibody M2 (Sigma) or the polyclonal anti-CERK antibody [9].
The blots were washed with TBS/T, then incubated with a 1:5000 dilu-
tion of horseradish peroxidase-conjugated anti-mouse IgG F(ab 0)2 or
anti-rabbit IgG F(ab 0)2 fragment (Amersham Biosciences). The
proteins were detected using an enhanced chemiluminescence (ECL)
western blotting detect reagent (Amersham Biosciences).
2.4. Susceptibility to trypsin digestion
Protein susceptibility to trypsin digestion was analyzed as described
previously [17]. Trypsin, diluted in 20 mM Tris–HCl (pH 7.5) to ﬁnal
concentrations of 0.001, 0.01, 0.1, 1, 10, 20, 40 and 60 lg/ml, was
added to lysates prepared from HEK293 cells expressing wild-type
CERK, CERK-L10I or CERK-L10A. Each mixture was incubated
at 25 C for 30 min, then the reaction was terminated by the addition
of SDS (ﬁnal concentration 1%). Samples were boiled for 5 min and
then subjected to Western blot analysis using an anti-CERK antibody.
2.5. Subcellular fractionation
HEK293 cells were transfected with a pcDNA3 expression vector
encoding CERK or CERK-L10I were harvested in 1 ml membrane
fractionation buﬀer (10 mM HEPES, 2 mM EGTA, 1 mM dithiothre-
itol, 40 mM KCl, 10% glycerol, and Completee protease inhibitor)
and centrifuged at 2000 · g. The supernatants were further centrifuged
at 100000 · g for 1 h at 4 C, and the resulting supernatant and pellet
were collected.2.6. Kinase assays
HEK293 cells were transfected with a pcDNA3 or pcDNA3-FLAG
expression vector encoding wild-type CERK or its mutants, and after
24 h, the cells were harvested and lysed. The CERK activity of each
cell lysate was assayed as described previously [9], using ceramide
(C18:0, d18:1; Avanti Polar Lipids) and [c-32P] ATP (Perkin–Elmer
Life Sciences) as substrates. The lipids were separated on Silica Gel
60 high performance TLC (HPTLC) plates (Merck) using chloro-
form/acetone/methanol/acetic acid/water (10:4:3:2:1, v/v) as the solvent
system for CERK assay. In some experiments, ceramide was added as
a complex with 1% BSA or 0.25% Triton X-100. To determine the ef-
fect of calcium on the enzyme activity, CaCl2 was diluted in lysis buﬀer
(10 mM HEPES, 1 mM dithiothreitol, 40 mM KCl, and Completee
protease inhibitor mixture) with the various concentrations (ﬁnal con-
centrations: 0.001, 0.01, 0.1, 0.5, 1, 5 and 10 mM), and added to the
reaction mixture (20 mM HEPES, 80 mM KCl, 1 mM cardiolipin,
1.5% b-octyl glucoside, 0.2 mM diethylenetriaminepentaacetic acid,
and 40 lM ceramide). CERK activities were then assessed in the pres-
ence of CaCl2. The SPHK activity of cell lysates was similarly assayed
as described previously [12], using D-erythro-sphingosine (Avanti Polar
Lipids) and [c-32P] ATP (Perkin–Elmer Life Sciences) as substrates.
The lipids were separated on Silica Gel 60 high performance TLC
(HPTLC) plates (Merck) using 1-butanol/acetic acid/water (3:1:1, v/
v) as the solvent system for SPHK assay. The labeled C1P or S1P
was quantiﬁed using a BAS 2500 imaging analyzer (Fuji Photo Film).
A unit of CERK activity was deﬁned as the amount of enzyme
required to produce 1 pmol of C1P per min. The kinetic data were
analyzed using Michaelis–Menten kinetics.3. Results
3.1. The PH domain of CERK is required for its enzyme activity
The N-terminus of CERK contains two sequence motifs, a
myristoylation site and a PH domain (Fig. 1A). N-terminal
myristoylation is a lipid anchor modiﬁcation found in eukary-
otic and viral proteins, which anchors them to membrane loca-
tions, and, thus, inﬂuences their cellular function [18]. PH
domains can mediate protein membrane association or activity
through high aﬃnity binding to phosphatidylinositol phos-
phate (PIP) [14,15,19].
To examine whether the PH domain is indispensably associ-
ated with CERK activity, we constructed FLAG-tagged
plasmids encoding full-length CERK, deletion of the CERK
(DPH-CERK, amino acids 127–531) and PH domain (PH-
CERK, amino acids 1–126), and transiently transfected them
intoHEK293 cells. After 24 h, the cells were lysed and, analyzed
byWestern blot to conﬁrm similar expression levels for the con-
structed proteins (Fig. 1B).We next examined the enzyme activ-
ity of the CERKmutants. As shown in Fig. 1C, deleting the PH
domain (DPH-CERK) completely eliminated the CERK activ-
ity. Since DPH-CERK exhibits high similarity to SPHK1, the
SPHK activities of wild-type CERK andDPH-CERKwere also
examined using D-erythro-sphingosine as a substrate, but nei-
ther exhibited any SPHK activity (Fig. 1D). Together, these re-
sults indicate that the presence of the N-terminal PH domain in
CERK is crucial for its enzyme activity but has no aﬀect on the
substrate speciﬁcity towards D-erythro-Sph.
3.2. The Leu10 residue in the PH domain of CERK is crucial for
its enzyme activity
In order to identify which region in the PH domain is crucial
for the enzyme activity, we constructed mutants of CERK that
were truncated at the N-terminus to various lengths (lacking 7,
12, or 76 residues), and examined their in vitro kinase activity.
As shown in Fig. 2A, the DN7-CERKmutant retained its activ-
ity, however, the DN12-CERK and DN76-CERK mutants
Fig. 1. Structural features and kinase activities of CERK and related mutants. (A) CERK harbors a protein sequence motif known as an N-terminal
PH domain. It is also myristoylated at its N-terminal glycine residue. (B–D) HEK293 cells were transiently transfected with an empty vector or with
plasmids encoding the FLAG-tagged versions of wild-type CERK, D-PH-CERK, PH-CERK or SPHK1a. Twenty-four hours after transfection, the
cells were harvested and lysed. (B) Proteins from cell lysates were resolved by SDS–PAGE, transferred to a nitrocellulose membrane, and blotted with
an anti-FLAGM2 antibody to analyze the protein expression. (C, D) CERK (C) or SPHK (D) assays were performed on cell lysates as described in
Section 2 using C18-Cer or Sph, respectively, as the substrate and [c-32P] ATP. PH, pleckstrin homology; DGK, diacylglycerol kinase.
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no acid sequence spanning residues 8–12 in the PH domain is
important for activity. Therefore, we next examined this region
more thoroughly using site-directed mutagenesis.
Four amino acids in the 8–12 region, Glu8, Pro9, Leu10, and
Ser12, were each mutated by substitution with Ala, the Gln11
residue is not conserved in human CERK, so it was not
mutated. Additionally, to examine the eﬀect of myristoylation
on the CERK activity, point mutation (CERK-G2A) abolish-
ing the myristoylation site (Gly2) was also constructed. The
CERK, CERK-G2A, CERK-E8A, CERK-P9A, CERK-
L10A and CERK-S12A mutants were expressed in HEK293
cells with similar levels (Fig. 2B, upper panel). In CERK assays
the CERK-G2A, CERK-E8A, CERK-P9A and CERK-S12A
mutations did not have any inﬂuence on the enzyme activity.
On the other hand, the CERK-L10A mutant dramatically lost
its activity, expressing less than 1% of the wild-type CERK
activity (Fig. 2B, lower panel). Next, the Leu10 residue was
replaced with Ile, which is structurally more similar to Leu
than Ala. Still, however, the CERK-L10I mutant exhibited
only a quarter of the activity of wild-type CERK (Fig. 2C,
lower panel). These results strongly suggest that N-terminal
myristoylation may not be important for CERK activity, but
that the Leu 10 residue is essential.To examine the possibility that mutating the Leu 10 residue
may have induced a large conformational change in the protein,
we explored the susceptibility of the proteins to trypsin diges-
tion. In the presence of various concentrations of trypsin, neither
of the mutants, CERK-L10A nor CERK-L10I, displayed any
diﬀerence in susceptibility from the wild-type CERK
(Fig. 2D). This result indicated that the decrease in CERKactiv-
ity observedwith theLeu10mutants is not directly related to any
large conformational changes caused by the Leu 10 substitution.
3.3. Subcellular fractionation and Ca2+-dependent activities of
CERK and CERK-L10I
CERK associates with the membrane in HEK293 cells [11].
To examine whether the decreased CERK activity was due to
a change in its membrane association, a membrane fraction-
ation experiment was performed on wild-type CERK and the
CERK-L10I mutant. As shown in Fig. 3A, protein expression
of either the CERK-L10I or wild-type CERK protein was
exclusively observed in the membrane fraction. Thus, the mem-
brane association of CERK may not be related to its activity.
CERK is known to be a calcium-dependent lipid kinase
[9,20]. Therefore, we examined the possibility that the
CERK-L10I mutation may aﬀect the calcium dependency of
the CERK activity. In order to remove the inﬂuence of
Fig. 2. Enzyme activities and susceptibility of CERK and its mutants. (A–C) Enzyme activities of CERK mutants. HEK293 cells were transiently
transfected with empty vector or with constructs encoding wild-type CERK, or the indicated truncated mutants (A) or site-directed mutants (B, C).
Twenty-four hours after transfection, the cells were harvested and lysed. Equal amounts of proteins from cell lysates were resolved by SDS-PAGE,
transferred to a nitrocellulose membrane, and blotted with an anti-CERK antibody to analyze the expression of the CERK mutants (upper panels).
To analyze the catalytic activities, C18-Cer was used as a substrate with [c-32P] ATP (lower panels). (D) Susceptibility to trypsin digestion. HEK293
cells were transiently transfected with empty vector, or constructs encoding wild-type CERK, CERK-L10A or CERK-L10I. The cell lysates (protein
concentration, 0.3 lg/ll) were incubated at 25 C for 30 min with the indicated concentration of trypsin, and then subjected to Western blot analysis
using an anti-CERK antibody.
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formed, and the activation of the CERK activity in the
membrane was examined in the presence of increasing concen-
trations of calcium. As shown in Fig. 3B, calcium stimulated
the activity of wild-type CERK in a concentration dependent
manner. A similar increase in activity was observed in the
CERK-L10I mutant, suggesting that the Leu10 residue is not
involved in the calcium dependency.
3.4. Substrate aﬃnities of CERK and CERK-L10I
A substrate kinetic analysis was performed to further char-
acterize the eﬀect of the Leu10 mutation on the CERK activ-
ity. The aﬃnities of wild-type CERK and the CERK-L10I
mutant for the enzyme substrates were measured in vitro using
various concentrations of Cer and ATP. The Km and Vmax
values for each enzyme toward Cer or ATP were calculated
by a Lineweaver–Burk plot. As shown in Fig. 3C, the Vmax
value for wild-type CERK was 3.41 ± 0.18 pmol/min/lg.
However, for the CERK-L10I mutant the Vmax value was
0.99 ± 0.29 pmol/min/lg, which was 29% of the value for
wild-type CERK. The Km values toward Cer of wild-type
CERK and CERK-L10I were 20.88 ± 3.27 and 19.20 ± 3.22lM, respectively, and the Km values for ATP were 85.59 ±
19.64 and 82.72 ± 17.54 lM, respectively. We could not
identify any diﬀerence in the Km values between the plots of
CERK-L10I and wild-type CERK, indicating that the
CERK-L10I mutation does not alter the substrate aﬃnity.
Thus, the Leu10 residue in the PH domain of CERK is
required for the activity of the enzyme, but not for substrate
binding. This result indicates that the PH domain might act
as a regulator on CERK activity.4. Discussion
In this study, we, for the ﬁrst time, demonstrated that the
PH domain of CERK is involved in its activity. Furthermore,
we established that Leu10 has an important role in the cata-
lytic activity of CERK. Other PH domains have been reported
to be associated with or activated at the membrane in intact
cells [14,15,19]. This raised the possibility that an association
of CERK with the membrane may be required for its activity.
We have recently determined that interactions between the PH
domain of CERK and certain PIP lipids induce the plasma
Fig. 3. Subcellular distribution, Ca2+-dependent activities and substrate kinetics of CERK and CERK-L10I. (A) Subcellular distribution of CERK
and CERK-L10I. Membrane fractionations of HEK293 cells expressing wild-type CERK or CERK-L10I were performed as described in Section 2.
Proteins from the total cell lysates (T) and the ﬁnal supernatant (S) and membrane (P) fractions were resolved by SDS–PAGE, transferred to
nitrocellulose, and blotted with an anti-CERK antibody. (B) Ca2+-dependent activities of CERK and CERK-L10I. HEK293 cells were transiently
transfected with plasmids encoding wild-type CERK or CERK-L10I and harvested after 24 h. In order to remove cytosolic calcium, total membrane
fractionation was performed as described in Section 2. The CERK activities were then measured using various concentrations of calcium. Results
from three independent experiments are represented as mean values ± S.D. (C) Substrate kinetics of CERK and CERK-L10I. Substrate kinetics for
wild-type CERK and CERK-L10I were measured using various concentrations of C18-Cer (upper left plot) or ATP (lower left plot). The Km values
toward Cer (upper right plot) or ATP (lower right plot) were calculated by a Lineweaver–Burk plot. Results from three independent experiments are
represented as mean values ± S.D.
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tion). In regard to its activity, though, our results here indi-
cated that an association of CERK with the membrane is
not required (Fig. 3A).
N-myristoylation, which generally regulates the cellular
function of modiﬁed proteins, is known to occur in CERK.
Very recently, Carre´ et al. [13] reported that they could not
identify any diﬀerences in the enzyme activity of CERK withor without N-myristoylation. In agreement with this report,
we observed similar levels of CERK activity in the CERK-
G2A and DN7-CERK mutants as in wild-type CERK
(Fig. 2A and B).
In contrast to the myristoylation, we established that the
Leu10 residue in the PH domain does have an important role
in the enzyme activity of CERK. To search for possible mech-
anisms underlying the decreases in activity in the Leu10
4388 T.-J. Kim et al. / FEBS Letters 579 (2005) 4383–4388mutants, we examined the eﬀect of the mutations on the sub-
strate aﬃnity, conformational change and calcium dependency
of the enzyme. A similar increase in activity in response to cal-
cium increases was observed in both the mutated and wild-type
enzymes (Fig. 3B). We recently identiﬁed a calcium/calmodulin
binding site in the C-terminal region of CERK (manuscript in
preparation), so it is likely that the PH domain is not related to
the calcium dependency of the enzyme.
In substrate kinetics assays, the CERK-L10I mutant exhib-
ited decreased CERK activity, but no change in substrate aﬃn-
ity for Cer or ATP (Fig. 3C). The putative ATP-binding site of
CERK, located in the C2 domain, is a GGDG motif [21], sim-
ilar to the SGDGx 17–21K motif in SPHK [12], therefore, the
PH domain in CERK is likely to be unrelated to ATP aﬃnity.
We also examined the substrate aﬃnity with Cer supplied as a
BSA or Triton-mixed complex, a widely used alternate delivery
system. Even under these conditions, the CERK-L10I muta-
tion still displayed lower activity than wild-type CERK, and
the substrate aﬃnity was not altered (data not shown), so
the decreased activity does not appear to be a consequence
of substrate presentation.
At the present stage, the molecular mechanism by which the
PH domain, including Leu10, exerts it inﬂuence on CERK
activity has not been fully explained.
In conclusion, we demonstrate here the importance of the
PH domain on CERK activity. In particular, the Leu10
residue in the PH domain of CERK may be required for its
catalytic activity but not for recognition of substrates. These
results indicate that the PH domain might act as a regulator
on CERK activity. The precise molecular mechanism behind
the eﬀect of the PH domain and Leu10 residue on the regula-
tion of CERK activity remains to be studied, and future stud-
ies utilizing structural analysis may aide in this discovery.
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